{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T06:50:51Z","timestamp":1774594251489,"version":"3.50.1"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI140287-05"],"award-info":[{"award-number":["R01AI140287-05"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jgar.2024.06.011","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:12:08Z","timestamp":1720656728000},"page":"252-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["In vitro evaluation of using ceftazidime\/avibactam against carbapenem-resistant Acinetobacter baumannii"],"prefix":"10.1016","volume":"38","author":[{"given":"Nazanin","family":"Pouya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0957-6762","authenticated-orcid":false,"given":"James E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cole S.","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7063-2191","authenticated-orcid":false,"given":"Nicholas S.","family":"Teran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7071-5376","authenticated-orcid":false,"given":"Vincent H.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2024.06.011_bib0001","doi-asserted-by":"crossref","first-page":"O1028","DOI":"10.1111\/1469-0691.12716","article-title":"A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia","volume":"20","author":"Nutman","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2024.06.011_bib0002","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.diagmicrobio.2012.04.007","article-title":"Antimicrobial resistance among gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008\u20132010)","volume":"73","author":"Gales","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2024.06.011_bib0003","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.ajic.2019.03.003","article-title":"Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis","volume":"47","author":"Du","year":"2019","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jgar.2024.06.011_bib0004","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1017\/ice.2020.450","article-title":"Epidemiology and clinical outcomes associated with extensively drug-resistant (XDR) Acinetobacter in US Veterans\u2019 Affairs (VA) medical centers","volume":"42","author":"Fitzpatrick","year":"2021","journal-title":"Infect Control Hospital Epidemiol"},{"key":"10.1016\/j.jgar.2024.06.011_bib0005","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cll.2019.05.006","article-title":"What the clinical microbiologist should know about pharmacokinetics\/pharmacodynamics in the era of emerging multidrug resistance: focusing on \u03b2-lactam\/\u03b2-lactamase inhibitor combinations","volume":"39","author":"Abodakpi","year":"2019","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.jgar.2024.06.011_bib0006","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1093\/jac\/dkac294","article-title":"Optimal ceftazidime\/avibactam dosing exposure against KPC-producing Klebsiella pneumoniae","volume":"77","author":"Tam","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2024.06.011_bib0007","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/1120009X.2021.2004363","article-title":"Hydrolytic activity of KPC-producing Klebsiella pneumoniae clinical isolates","volume":"34","author":"Tam","year":"2022","journal-title":"J Chemother"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716524001218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716524001218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T08:47:33Z","timestamp":1726390053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716524001218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":7,"alternative-id":["S2213716524001218"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2024.06.011","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro evaluation of using ceftazidime\/avibactam against carbapenem-resistant Acinetobacter baumannii","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2024.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}